{"id":16425,"date":"2013-03-22T17:30:00","date_gmt":"2013-03-22T16:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/pfizer-inc-il-ceo-ian-read-intasca-18-milioni-nel-2012\/"},"modified":"2013-03-22T17:30:00","modified_gmt":"2013-03-22T16:30:00","slug":"pfizer-inc-il-ceo-ian-read-intasca-18-milioni-nel-2012","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/pfizer-inc-il-ceo-ian-read-intasca-18-milioni-nel-2012\/","title":{"rendered":"Pfizer Inc. CEO Ian Read pockets $ 18 million in 2012"},"content":{"rendered":"<p style=\"text-align: left\"><em><span style=\"line-height: 115%; font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: IT; mso-fareast-language: IT; mso-bidi-language: AR-SA\">Per <\/span><\/em><span lang=\"EN-US\" style=\"line-height: 115%; font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: IT; mso-bidi-language: AR-SA\"><a href=\"http:\/\/connect.mlive.com\/user\/uzerilli\/posts.html\" target=\"_blank\" rel=\"noopener\"><em><span lang=\"IT\" style=\"color: #363636; text-decoration: none; mso-ansi-language: IT; text-underline: none\">Ursula Zerilli | <\/span><\/em><\/a><a href=\"mailto:uzerilli@mlive.comMLive.com\"><em>uzerilli@mlive.com<\/em><\/a><\/span><em><span lang=\"EN-US\" style=\"line-height: 115%; font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: IT; mso-bidi-language: AR-SA\"> [Michigam Live]<\/span><span style=\"line-height: 115%; display: none; font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: IT; mso-fareast-language: IT; mso-bidi-language: AR-SA; mso-hide: all\">MLive.com<\/span><span style=\"line-height: 115%; font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: IT; mso-fareast-language: IT; mso-bidi-language: AR-SA\"><br \/> il 19 marzo 2013 a 08:00, aggiornamento 19 Marzo, 2013 alle 08:09<\/span><\/em><\/p>\n<p style=\"text-align: left\">&nbsp;<\/p>\n<p style=\"text-align: left\">&nbsp;<img loading=\"lazy\" decoding=\"async\" class=\"adv-photo\" alt=\"10706721-large.jpg\" width=\"380\" height=\"266\" src=\"http:\/\/media.mlive.com\/businessreview\/western_impact\/photo\/10856948-large.jpg\" \/><\/p>\n<p style=\"text-align: left\"><b><span style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">Kalamazoo, MI &#8211;<\/span><\/b><span style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"> Ian Read, CEO di <\/span><span lang=\"EN-US\" style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: IT\"><a href=\"http:\/\/topics.mlive.com\/tag\/Pfizer\/index.html\" target=\"_blank\" rel=\"noopener\"><span lang=\"IT\" style=\"color: #363636; text-decoration: none; mso-ansi-language: IT; text-underline: none\">Pfizer Inc.<\/span><\/a><\/span><span style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"> , la pi&ugrave; grande azienda farmaceutica del mondo, ha intascato $ 18 milioni nel 2012. <\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; background: white\"><span style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; line-height: normal; margin: 0cm 0cm 0pt; background: white\"><span lang=\"EN-US\" style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: IT\"><a href=\"http:\/\/www.usatoday.com\/story\/money\/business\/2013\/03\/14\/pfizer-ceo-read-18-million\/1988013\/\" target=\"_blank\" rel=\"noopener\"><span lang=\"IT\" style=\"color: #363636; text-decoration: none; mso-ansi-language: IT; text-underline: none\">USA Today <\/span><\/a><\/span><span style=\"font-family: 'Helvetica','sans-serif'; color: #363636; font-size: 12pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: IT\">nel suo rapporto riferisce che ha visto il suo incremento delle retribuzioni di $<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Per Ursula Zerilli | uzerilli@mlive.com [Michigam Live]MLive.com il 19 marzo 2013 a 08:00, aggiornamento 19 Marzo, 2013 alle 08:09 &nbsp; &nbsp; Kalamazoo, MI &#8211; Ian Read, CEO di Pfizer Inc. , la pi&ugrave; grande azienda farmaceutica del mondo, ha intascato $ 18 milioni nel 2012. &nbsp; USA Today nel suo rapporto riferisce che ha visto &hellip;<\/p>\n","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-16425","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16425","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=16425"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/16425\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=16425"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=16425"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=16425"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}